The viability of using alternative sites to increase rates of adolescent vaccination (or: 'a rising tide floats all boats').

摘要

Since 2005, the number of vaccines routinely administered to adolescents has rapidly increased, with new recommendations for quadrivalent meningococcal conjugate vaccine (MCV4); tetanus toxoid, diphtheria, and acellular pertussis (Tdap) vaccine; human papillomavirus (HPV; quadrivalent [HPV4] and bivalent [HPV2]) vaccine; and seasonal influenza vaccine, as well as catch-up vaccination against hepatitis A for adolescents in states/communities with existing hepatitis control programs in place, those at increased risk, and those desiring to be protected [1]. Also, a second dose of varicella vaccine was recommended for adolescents without a history of varicella disease who have received only a single dose [2].